"We will make every diabetic patient in China have his own blood sugar meter." With this dream in mind, Sannuo Bio was founded in 2002, embarking on the journey of promoting economical and affordable blood sugar monitoring products in China and developing the local diabetes health industry. Adhering to the core values of "No for Love", Sannuo Bio has always been committed to innovation in biosensing technology, developing, producing and selling a series of rapid diagnostic and testing products for patients with chronic diseases and medical and health professionals. Since its establishment, Sanno blood glucose meter, characterized by "accuracy, simplicity and economical", has received unanimous praise from Chinese consumers. In China, more than 50% of diabetic patients use Sannuo's products. The company can proudly claim that the company has successfully promoted the popularization of blood glucose meters in China and the self-glycemic management results of Chinese diabetic patients. However, giving diabetics a blood glucose meter is only the company's first step. In order to achieve the goal of effectively controlling blood sugar levels, diabetic patients need to systematically learn related knowledge such as blood sugar monitoring, diet, and exercise. Therefore, the company is actively expanding into the field of diabetes medical services, creating a "hardware + software + service" model to help diabetic patients understand and master comprehensive diabetes management, and move towards the goal of "from promoter of blood glucose meters to diabetes digital management experts" . This goal inspired every Sannuo employee. From this, the company provided a more advanced blood sugar monitoring system, developed a multi-analyte analyzer to provide more diabetes-related information, and launched a hospital diabetes management platform. , create a closed loop between doctors, patients, nutritionists and diabetes educators. In September 2014, they all acquired Beijing Sannuojianheng Diabetes Hospital and launched a pilot program in the field of diabetes medical services; in January 2016, they participated in the acquisition of Trividia Health Inc, the United States, taking the first step of internationalization, and entering the The frontier of the global blood glucose meter industry; in July 2016, it acquired Polymer Technology Systems, Inc., a joint venture with external strategic investors, actively expanding its POCT detection business and providing a more comprehensive overall solution for chronic disease prevention and control. Ultimately, the company will form an ecosystem of diabetes management, providing a systematic solution to improve the quality of life of diabetic patients, reduce the communication costs between health care providers and patients, and improve the social health care economy.
Sinocare Inc.
"We will make every diabetic patient in China have his own blood sugar meter." With this dream in mind, Sannuo Bio was founded in 2002, embarking on the journey of promoting economical and affordable blood sugar monitoring products in China and developing the local diabetes health industry. Adhering to the core values of "No for Love", Sannuo Bio has always been committed to innovation in biosensing technology, developing, producing and selling a series of rapid diagnostic and testing products for patients with chronic diseases and medical and health professionals. Since its establishment, Sanno blood glucose meter, characterized by "accuracy, simplicity and economical", has received unanimous praise from Chinese consumers. In China, more than 50% of diabetic patients use Sannuo's products. The company can proudly claim that the company has successfully promoted the popularization of blood glucose meters in China and the self-glycemic management results of Chinese diabetic patients. However, giving diabetics a blood glucose meter is only the company's first step. In order to achieve the goal of effectively controlling blood sugar levels, diabetic patients need to systematically learn related knowledge such as blood sugar monitoring, diet, and exercise. Therefore, the company is actively expanding into the field of diabetes medical services, creating a "hardware + software + service" model to help diabetic patients understand and master comprehensive diabetes management, and move towards the goal of "from promoter of blood glucose meters to diabetes digital management experts" . This goal inspired every Sannuo employee. From this, the company provided a more advanced blood sugar monitoring system, developed a multi-analyte analyzer to provide more diabetes-related information, and launched a hospital diabetes management platform. , create a closed loop between doctors, patients, nutritionists and diabetes educators. In September 2014, they all acquired Beijing Sannuojianheng Diabetes Hospital and launched a pilot program in the field of diabetes medical services; in January 2016, they participated in the acquisition of Trividia Health Inc, the United States, taking the first step of internationalization, and entering the The frontier of the global blood glucose meter industry; in July 2016, it acquired Polymer Technology Systems, Inc., a joint venture with external strategic investors, actively expanding its POCT detection business and providing a more comprehensive overall solution for chronic disease prevention and control. Ultimately, the company will form an ecosystem of diabetes management, providing a systematic solution to improve the quality of life of diabetic patients, reduce the communication costs between health care providers and patients, and improve the social health care economy.
Qinli Biotechnology Co., Ltd.
Qinli Biotechnology Co., Ltd. aims to create a distinctive and competitive biotechnology company. In the clinical testing market, central fully automated instruments with a large number of rapid testing functions dominate most of the market, just as supercomputers in early information systems were dominated by large companies. Biosensors are just like current personal computers, and can be widely accepted by the public around the world and have a huge growth rate. The company's research and development is aimed at two major fields. One is based on screen printing electrode technology and key electrochemical detection technologies, combined with the advantages of domestic electronic technology, and develops biosensor products for clinical, environmental protection, national defense, animal use, agricultural use, and gene use. Testing and other fields. Based on the technical platform developed by the company, any company that has electrochemical activity in the detection project itself or can produce electrochemical activity through enzymes or other special reactions is capable of developing relevant biosensors. The second is microbial and genetic engineering technology, the development of healthy food and clinical immunoassay reagents. Company culture lies in cultivating the vitality of continuous innovation and pursuit of excellence, and contributing to the enhancement of human health and quality of life.
Qinli Biotechnology Co., Ltd.
Qinli Biotechnology Co., Ltd. aims to create a distinctive and competitive biotechnology company. In the clinical testing market, central fully automated instruments with a large number of rapid testing functions dominate most of the market, just as supercomputers in early information systems were dominated by large companies. Biosensors are just like current personal computers, and can be widely accepted by the public around the world and have a huge growth rate. The company's research and development is aimed at two major fields. One is based on screen printing electrode technology and key electrochemical detection technologies, combined with the advantages of domestic electronic technology, and develops biosensor products for clinical, environmental protection, national defense, animal use, agricultural use, and gene use. Testing and other fields. Based on the technical platform developed by the company, any company that has electrochemical activity in the detection project itself or can produce electrochemical activity through enzymes or other special reactions is capable of developing relevant biosensors. The second is microbial and genetic engineering technology, the development of healthy food and clinical immunoassay reagents. Company culture lies in cultivating the vitality of continuous innovation and pursuit of excellence, and contributing to the enhancement of human health and quality of life.
Beijing Yicheng Bio - Electronics Technology Co., Ltd.
Beijing Yicheng Bioelectronics Technology Co., Ltd. was established in 1993. It is an excellent domestic blood glucose meter manufacturer, a national high-tech enterprise, Zhongguancun high-tech enterprise, a national technology research and development plan (863 plan ) support enterprise, and China medical rapid testing. Professional manufacturers in the field. The company's main business is the research, development, production and sales of in vitro diagnostic rapid testing products (including instruments and in vitro diagnostic reagents) for diabetes and complications, and provides them with comprehensive personal health management services related to it. The company comprehensively uses electrochemical biosensor technology, immunolabeling chromatography technology and human sign detection technology to form a blood sugar monitoring system, mainly blood ketone body test, blood uric acid test, urine microalbumin test, card-type electrocardiogram A rich product line supplemented by detectors and other products. At the same time, the company also has some health products production and sales business, and its main products are Yicheng Pure Cordyceps mycelium capsules, etc. In addition to the above products, the company has begun to operate the online chronic disease management platform - Yicheng Network Hospital, expanding its business to the downstream health service field. The Yicheng Network Hospital built by the company aims to use Internet technology to connect equipment with medical service resources and provide online personal comprehensive health management services for patients with chronic diseases. Since its establishment, Yicheng Bio has been committed to relying on continuous technological development to provide diverse and advanced rapid testing products to all sectors of society, constantly meeting human pursuit of health. The company's doctoral, master's and engineer teams carry out independent research and development work. The technical team members graduated from Tsinghua University, Peking University, Academy of Military Medical Sciences, University of Chinese Academy of Sciences, University of Bochum, University of Saskatchewan, and other well-known domestic and foreign universities. They have long been Engaged in the research and development of electrochemical biosensor technology, gold standard immunochromatography technology, biochip technology, biochemical analysis kits, antibody reagents and other fields. The company has complete independent intellectual property rights in various core technical links and owns a total of 26 patents.
Beijing Yicheng Bio - Electronics Technology Co., Ltd.
Beijing Yicheng Bioelectronics Technology Co., Ltd. was established in 1993. It is an excellent domestic blood glucose meter manufacturer, a national high-tech enterprise, Zhongguancun high-tech enterprise, a national technology research and development plan (863 plan ) support enterprise, and China medical rapid testing. Professional manufacturers in the field. The company's main business is the research, development, production and sales of in vitro diagnostic rapid testing products (including instruments and in vitro diagnostic reagents) for diabetes and complications, and provides them with comprehensive personal health management services related to it. The company comprehensively uses electrochemical biosensor technology, immunolabeling chromatography technology and human sign detection technology to form a blood sugar monitoring system, mainly blood ketone body test, blood uric acid test, urine microalbumin test, card-type electrocardiogram A rich product line supplemented by detectors and other products. At the same time, the company also has some health products production and sales business, and its main products are Yicheng Pure Cordyceps mycelium capsules, etc. In addition to the above products, the company has begun to operate the online chronic disease management platform - Yicheng Network Hospital, expanding its business to the downstream health service field. The Yicheng Network Hospital built by the company aims to use Internet technology to connect equipment with medical service resources and provide online personal comprehensive health management services for patients with chronic diseases. Since its establishment, Yicheng Bio has been committed to relying on continuous technological development to provide diverse and advanced rapid testing products to all sectors of society, constantly meeting human pursuit of health. The company's doctoral, master's and engineer teams carry out independent research and development work. The technical team members graduated from Tsinghua University, Peking University, Academy of Military Medical Sciences, University of Chinese Academy of Sciences, University of Bochum, University of Saskatchewan, and other well-known domestic and foreign universities. They have long been Engaged in the research and development of electrochemical biosensor technology, gold standard immunochromatography technology, biochip technology, biochemical analysis kits, antibody reagents and other fields. The company has complete independent intellectual property rights in various core technical links and owns a total of 26 patents.
Hangzhou Biotest Biotechnology Co., Ltd.
Hangzhou Weice Biotechnology Co., Ltd. is a high-tech enterprise located in Linping District, Hangzhou. Since its establishment in August 2013, it has been specialized in the research and development, production and sales of POCT products. Weice Biotech has always adhered to the development concept of "making health management within reach", committed to building an ecological system of "chronic disease management + rapid diagnosis + digital medical care", and strived to become a globally trusted smart POCT provider. Weice Biotechnology has established and maintained a quality management system that complies with the requirements of medical device production quality management specifications, the Appendix to the In vitro diagnostic reagents, (EN)ISO13485:2016, MDSAP includes the 21CFRPart820 requirements, and implements continuous measurement, analysis and Improvements to fully meet applicable regulations, standards and customer needs. At the same time, the product has been certified by many countries and regions such as China's NMPA, EU CE, and the US FDA. Weice Bio has been deeply engaged in overseas markets and has strong advantages. Its products have been exported to more than 100 countries and regions including the United States, Italy, Germany, Turkey, etc., and have been widely recognized by local customers. It has established overseas subsidies in the United States, Hong Kong and India. company. In the Chinese market, Weice Bio products are sold to nearly 900 secondary and above hospitals. Weice Biotech has strong technological research and development and innovation capabilities. The NB-IoT Internet of Things 5G blood glucose meter independently developed in January 2021 was successfully launched. Weice Bio attaches great importance to intellectual property protection and protects the company's intellectual property rights through trademark application, patent application and other means. At present, the company has hundreds of patents and software copyrights.
Hangzhou Biotest Biotechnology Co., Ltd.
Hangzhou Weice Biotechnology Co., Ltd. is a high-tech enterprise located in Linping District, Hangzhou. Since its establishment in August 2013, it has been specialized in the research and development, production and sales of POCT products. Weice Biotech has always adhered to the development concept of "making health management within reach", committed to building an ecological system of "chronic disease management + rapid diagnosis + digital medical care", and strived to become a globally trusted smart POCT provider. Weice Biotechnology has established and maintained a quality management system that complies with the requirements of medical device production quality management specifications, the Appendix to the In vitro diagnostic reagents, (EN)ISO13485:2016, MDSAP includes the 21CFRPart820 requirements, and implements continuous measurement, analysis and Improvements to fully meet applicable regulations, standards and customer needs. At the same time, the product has been certified by many countries and regions such as China's NMPA, EU CE, and the US FDA. Weice Bio has been deeply engaged in overseas markets and has strong advantages. Its products have been exported to more than 100 countries and regions including the United States, Italy, Germany, Turkey, etc., and have been widely recognized by local customers. It has established overseas subsidies in the United States, Hong Kong and India. company. In the Chinese market, Weice Bio products are sold to nearly 900 secondary and above hospitals. Weice Biotech has strong technological research and development and innovation capabilities. The NB-IoT Internet of Things 5G blood glucose meter independently developed in January 2021 was successfully launched. Weice Bio attaches great importance to intellectual property protection and protects the company's intellectual property rights through trademark application, patent application and other means. At present, the company has hundreds of patents and software copyrights.
Nanjing Jingjie Biotechnology Co., Ltd.
Nanjing Jingjie Biotechnology Co., Ltd. was established in 2017. Relying on the years of R&D accumulation of well-known universities at home and abroad, it integrates talents in the fields of chemistry, materials, electronics, software, machinery, biomedical engineering, etc., and adheres to strict quality. Management system, committed to the research and development, production and sales of well-known POCT (Point-of-Care Testing) and health management products, providing the world with high-quality and innovative testing and health management products and services, and promoting personality through testing and technological innovation. Carry out health management and become the guardian of human health!
Nanjing Jingjie Biotechnology Co., Ltd.
Nanjing Jingjie Biotechnology Co., Ltd. was established in 2017. Relying on the years of R&D accumulation of well-known universities at home and abroad, it integrates talents in the fields of chemistry, materials, electronics, software, machinery, biomedical engineering, etc., and adheres to strict quality. Management system, committed to the research and development, production and sales of well-known POCT (Point-of-Care Testing) and health management products, providing the world with high-quality and innovative testing and health management products and services, and promoting personality through testing and technological innovation. Carry out health management and become the guardian of human health!
Guilin Urit Medical Electronic Co., Ltd.
Guilin Youlit Electronics Group Co., Ltd. is a domestic manufacturer, supplier and service provider of medical diagnostic products. Forge ahead for thirty years and focus on testing for health. Ulit has keenly grasped the development trend of medical technology innovation and development, based on the needs of clinical medical diagnosis, and has developed eight series of products including hemorrhage cell analysis, urine analysis, and biochemical analysis. Today, Ulit has developed into a large health and medical technology group integrating R&D, production, sales and services. Its entire business is sold in more than 180 countries and regions around the world, and has been used in more than 200,000 medical institutions around the world for billions of people. Bring health and care to become one of the brands of clinical diagnostic equipment selection.
Guilin Urit Medical Electronic Co., Ltd.
Guilin Youlit Electronics Group Co., Ltd. is a domestic manufacturer, supplier and service provider of medical diagnostic products. Forge ahead for thirty years and focus on testing for health. Ulit has keenly grasped the development trend of medical technology innovation and development, based on the needs of clinical medical diagnosis, and has developed eight series of products including hemorrhage cell analysis, urine analysis, and biochemical analysis. Today, Ulit has developed into a large health and medical technology group integrating R&D, production, sales and services. Its entire business is sold in more than 180 countries and regions around the world, and has been used in more than 200,000 medical institutions around the world for billions of people. Bring health and care to become one of the brands of clinical diagnostic equipment selection.
Acon Biotech (Hangzhou) Co., Ltd.
Aikon On •Call® is a brand launched by Aikon Biotechnology (Hangzhou) Co., Ltd. in 2004 specifically targeted patients and doctors with chronic diseases. Aike integrates biology, medicine, electronics, information and other technologies, with blood sugar detection as the core, and its products cover four major chronic diseases, including diabetes, hypertension, hyperlipidemia, and hyperuric acid, as well as cardiovascular diseases, thyroid diseases, respiratory diseases, A number of testing indicators in the fields of kidney disease and other fields provide a variety of simple, fast and accurate testing solutions for patients with various chronic diseases. Aike is committed to building a full network system for chronic disease prevention and control, providing overall solutions for chronic disease patients around the world. With its deep understanding of chronic disease management and the advantages of product research and development accumulated over the years, Aike has become the first key brand for medical staff and related chronic disease educators around the world. Keeping health online is Aike’s promise to patients. We have established in-depth cooperation with medical institutions at all levels and major chain pharmacies across the country, providing professional health consultation and product training before sales; providing product lifelong warranty services after sales, and building a scientific self-health management platform for chronic disease patients. Aike serves every user with a scientific attitude, professional level and standardized system.
Acon Biotech (Hangzhou) Co., Ltd.
Aikon On •Call® is a brand launched by Aikon Biotechnology (Hangzhou) Co., Ltd. in 2004 specifically targeted patients and doctors with chronic diseases. Aike integrates biology, medicine, electronics, information and other technologies, with blood sugar detection as the core, and its products cover four major chronic diseases, including diabetes, hypertension, hyperlipidemia, and hyperuric acid, as well as cardiovascular diseases, thyroid diseases, respiratory diseases, A number of testing indicators in the fields of kidney disease and other fields provide a variety of simple, fast and accurate testing solutions for patients with various chronic diseases. Aike is committed to building a full network system for chronic disease prevention and control, providing overall solutions for chronic disease patients around the world. With its deep understanding of chronic disease management and the advantages of product research and development accumulated over the years, Aike has become the first key brand for medical staff and related chronic disease educators around the world. Keeping health online is Aike’s promise to patients. We have established in-depth cooperation with medical institutions at all levels and major chain pharmacies across the country, providing professional health consultation and product training before sales; providing product lifelong warranty services after sales, and building a scientific self-health management platform for chronic disease patients. Aike serves every user with a scientific attitude, professional level and standardized system.
Fosun Diagnostic Technologies (Shanghai) Co., Ltd.
The Zhongshengkang brand was founded in 2009. Zhongshengkang's products mainly include needle cotton, test paper boxes, blood sugar measurement instruments, analyzers, household blood sugar meters, test strips, and blood sugar meters. Fosun Diagnostic Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Fosun Diagnostic") was founded in 1989. It adheres to the mission of "integrating innovative diagnostic technology and protecting global life and health", promotes the development and implementation of innovative technologies and products, and focuses on external use. The diagnostic industry is committed to becoming a global advanced technology innovator in the overall medical diagnosis solution. On May 18, 2021, "Fosun Long March" was officially renamed "Fosun Diagnosis". Six major R&D and production bases have been established in China, and have been deeply involved in Shanghai, Jiangsu, Hunan, Anhui, Shenzhen and other provinces and cities, and have continuously improved in vitro diagnosis. The integrated industrial layout of instruments and reagent research and development and manufacturing, the products involve clinical chemistry, clinical immunity, molecular diagnosis, microbial, POCT and other laboratory medicine fields, focusing on tumors, digestive metabolism, cardiovascular and cerebrovascular, and large reproduction. A large-scale fully automatic assembly line and a small POCT product group will be built in six major diseases such as central nervous system and infection.
Fosun Diagnostic Technologies (Shanghai) Co., Ltd.
The Zhongshengkang brand was founded in 2009. Zhongshengkang's products mainly include needle cotton, test paper boxes, blood sugar measurement instruments, analyzers, household blood sugar meters, test strips, and blood sugar meters. Fosun Diagnostic Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Fosun Diagnostic") was founded in 1989. It adheres to the mission of "integrating innovative diagnostic technology and protecting global life and health", promotes the development and implementation of innovative technologies and products, and focuses on external use. The diagnostic industry is committed to becoming a global advanced technology innovator in the overall medical diagnosis solution. On May 18, 2021, "Fosun Long March" was officially renamed "Fosun Diagnosis". Six major R&D and production bases have been established in China, and have been deeply involved in Shanghai, Jiangsu, Hunan, Anhui, Shenzhen and other provinces and cities, and have continuously improved in vitro diagnosis. The integrated industrial layout of instruments and reagent research and development and manufacturing, the products involve clinical chemistry, clinical immunity, molecular diagnosis, microbial, POCT and other laboratory medicine fields, focusing on tumors, digestive metabolism, cardiovascular and cerebrovascular, and large reproduction. A large-scale fully automatic assembly line and a small POCT product group will be built in six major diseases such as central nervous system and infection.
ForaCare specializes in blood glucose meters and other health monitoring devices, emphasizing user-friendly designs.
ForaCare Inc.
ForaCare specializes in blood glucose meters and other health monitoring devices, emphasizing user-friendly designs.
True Metrix offers blood glucose meters with no-coding technology and affordable test strips for diabetes management.
Trividia Health
True Metrix offers blood glucose meters with no-coding technology and affordable test strips for diabetes management.
GlucoMen provides a range of blood glucose meters with advanced features for accurate diabetes monitoring.
A. Menarini Diagnostics
GlucoMen provides a range of blood glucose meters with advanced features for accurate diabetes monitoring.
Dario offers a compact, smartphone-connected blood glucose meter for convenient diabetes management.
DarioHealth Corp.
Dario offers a compact, smartphone-connected blood glucose meter for convenient diabetes management.
Bayer Contour is a trusted brand for blood glucose meters, known for their accuracy and ease of use.
Bayer AG
Bayer Contour is a trusted brand for blood glucose meters, known for their accuracy and ease of use.
CareSens provides affordable and reliable blood glucose monitoring systems with a focus on simplicity and accuracy.
i-SENS, Inc.
CareSens provides affordable and reliable blood glucose monitoring systems with a focus on simplicity and accuracy.
Contour is known for its advanced blood glucose meters with features like color-coded results and Bluetooth connectivity.
Ascensia Diabetes Care
Contour is known for its advanced blood glucose meters with features like color-coded results and Bluetooth connectivity.
Berlan Medical (Shanghai) International Trade Co., Ltd., a well-known (famous) blood glucose meter brand, was founded in Germany in 1839. It is one of the world's most prestigious medical device manufacturing suppliers and one of the world's largest suppliers of professional medical equipment, pharmaceutical products and surgical medical devices. German Berlan Medical Co., Ltd. was established in 1839 and is one of the world's prestigious medical device manufacturing suppliers. Its headquarters is located in Meltsonggen, Germany. The group has 129 institutions all over the world. It has factories, offices and repair stations in more than 50 countries including Germany, France, Spain, Japan, Malaysia, China, etc. Its main subsidiaries include German Snake Brand Company and American MCGAW Company, and its predecessors are listed companies in Germany and the United States. Due to Berlan's outstanding achievements in R&D, its products have been continuously innovated and marketed all over the world. Berland Medical (Shanghai) International Trade Co., Ltd. was established in December 1999 and is a wholly owned company of Berland Group in Germany. The registered address is No. 285, Gangmao Road, Waigaoqiao Free Trade Zone, Shanghai. There is a business office in the Lujiazui area of Pudong. The legal representative and chairman is Mr. Christian Hildebrandt. The company's main business is importing products of the group and selling them in China. Berland Group currently has two joint ventures in China, namely "Shenyang Berland Pharmaceutical Co., Ltd.", which produces plasma substitute - Jialufax. "Shepai Xinhua Surgical Instrument Co., Ltd." produces Shepai surgical instruments. Berlan Company has representative offices in major cities in China, such as Beijing, Guangzhou, Wuhan, Shenyang, Xi'an, Chengdu, etc., and contacts domestic business. The total number of domestic employees is more than 500. Berlan Group has a strict management system, and is a company certified by TUV to pass the ISO9002 management system. Berlan Company attaches great importance to employee training, customer business training and after-sales service, and has set up the "Snake Brand" Academy and maintenance station in Shanghai. Berlan has also established scientific research centers around the world to focus on the research, manufacturing and market development of medical products. For its own sake, Berlan Group has always been at the forefront of the medical field, setting new milestones in the medical field through unremitting efforts, and enjoying a reputation for reliability and responsibility around the world. The driving force behind the continuous progress and success of Berlan Company is: ethics, integrity, creativity, forward-looking, and many years of experience in the field of medical product research and development. Berlan will continue to be committed to professional research and high-quality creation, and contribute more to medical care worldwide. Because---human health is our goal of continuous innovation!
B. Braun Melsungen AG
Berlan Medical (Shanghai) International Trade Co., Ltd., a well-known (famous) blood glucose meter brand, was founded in Germany in 1839. It is one of the world's most prestigious medical device manufacturing suppliers and one of the world's largest suppliers of professional medical equipment, pharmaceutical products and surgical medical devices. German Berlan Medical Co., Ltd. was established in 1839 and is one of the world's prestigious medical device manufacturing suppliers. Its headquarters is located in Meltsonggen, Germany. The group has 129 institutions all over the world. It has factories, offices and repair stations in more than 50 countries including Germany, France, Spain, Japan, Malaysia, China, etc. Its main subsidiaries include German Snake Brand Company and American MCGAW Company, and its predecessors are listed companies in Germany and the United States. Due to Berlan's outstanding achievements in R&D, its products have been continuously innovated and marketed all over the world. Berland Medical (Shanghai) International Trade Co., Ltd. was established in December 1999 and is a wholly owned company of Berland Group in Germany. The registered address is No. 285, Gangmao Road, Waigaoqiao Free Trade Zone, Shanghai. There is a business office in the Lujiazui area of Pudong. The legal representative and chairman is Mr. Christian Hildebrandt. The company's main business is importing products of the group and selling them in China. Berland Group currently has two joint ventures in China, namely "Shenyang Berland Pharmaceutical Co., Ltd.", which produces plasma substitute - Jialufax. "Shepai Xinhua Surgical Instrument Co., Ltd." produces Shepai surgical instruments. Berlan Company has representative offices in major cities in China, such as Beijing, Guangzhou, Wuhan, Shenyang, Xi'an, Chengdu, etc., and contacts domestic business. The total number of domestic employees is more than 500. Berlan Group has a strict management system, and is a company certified by TUV to pass the ISO9002 management system. Berlan Company attaches great importance to employee training, customer business training and after-sales service, and has set up the "Snake Brand" Academy and maintenance station in Shanghai. Berlan has also established scientific research centers around the world to focus on the research, manufacturing and market development of medical products. For its own sake, Berlan Group has always been at the forefront of the medical field, setting new milestones in the medical field through unremitting efforts, and enjoying a reputation for reliability and responsibility around the world. The driving force behind the continuous progress and success of Berlan Company is: ethics, integrity, creativity, forward-looking, and many years of experience in the field of medical product research and development. Berlan will continue to be committed to professional research and high-quality creation, and contribute more to medical care worldwide. Because---human health is our goal of continuous innovation!
Roche Diagnostics Products (Shanghai) Co., Ltd.
Roche Diagnostics focuses on developing and providing innovative, cost-effective, timely and stable diagnostic systems and solutions from early detection, prevention to diagnosis and monitoring of diseases, thereby helping medical staff improve patients' treatment effects and improve people's quality of life. Reduce social medical costs. Roche Group has a unique position in the medical industry to lead innovatively across diagnostic and pharmaceutical fields. This combination allows us to apply breakthrough disease knowledge to develop innovative products, discover and monitor diseases, and guide the choice of treatment options. In August 2000, Luoche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in mainland China. Since its establishment, the company's business has been growing and its scale has continued to grow. It is a leader in China's in vitro diagnostic market. To date, the company has more than 2,000 employees, distributed in more than 70 cities across the country. The company is headquartered in Shanghai and has established branches in Beijing, Guangzhou, Nanjing, Hangzhou and Jinan. The company's product sales and service network is spread all over the country. With its outstanding technical products and perfect services, it has won a wide market and reputation. Roche Diagnostics has made a firm commitment to the Chinese market and will contribute to China's medical and healthcare cause and the improvement of people's quality of life by improving testing efficiency and medical value.
Roche Diagnostics Products (Shanghai) Co., Ltd.
Roche Diagnostics focuses on developing and providing innovative, cost-effective, timely and stable diagnostic systems and solutions from early detection, prevention to diagnosis and monitoring of diseases, thereby helping medical staff improve patients' treatment effects and improve people's quality of life. Reduce social medical costs. Roche Group has a unique position in the medical industry to lead innovatively across diagnostic and pharmaceutical fields. This combination allows us to apply breakthrough disease knowledge to develop innovative products, discover and monitor diseases, and guide the choice of treatment options. In August 2000, Luoche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in mainland China. Since its establishment, the company's business has been growing and its scale has continued to grow. It is a leader in China's in vitro diagnostic market. To date, the company has more than 2,000 employees, distributed in more than 70 cities across the country. The company is headquartered in Shanghai and has established branches in Beijing, Guangzhou, Nanjing, Hangzhou and Jinan. The company's product sales and service network is spread all over the country. With its outstanding technical products and perfect services, it has won a wide market and reputation. Roche Diagnostics has made a firm commitment to the Chinese market and will contribute to China's medical and healthcare cause and the improvement of people's quality of life by improving testing efficiency and medical value.
Glucocard offers blood glucose meters with advanced technology for accurate and reliable diabetes monitoring.
Arkray, Inc.
Glucocard offers blood glucose meters with advanced technology for accurate and reliable diabetes monitoring.
Johnson & Johnson (China) Investment Co., Ltd.
Wenjie OneTouch was originally affiliated to Johnson & Johnson Group, a century-old international brand. It is a sub-brand of Johnson & Johnson, a subsidiary of the United States that specializes in the production of blood sugar monitoring products (JPY is referred to as Johnson & Johnson's blood sugar meter for short). Now Johnson & Johnson's blood sugar meter has been renamed Wenjie blood sugar meter. In 1987, the Wenjie OneTouch brand was born, becoming a milestone in the development history of pocket blood glucose meters. In 1994, Johnson & Johnson introduced Steady OneTouch to the Chinese market to help Chinese diabetic patients monitor and control blood sugar. Since entering the Chinese market, Wenjie OneTouch has not only been committed to continuously improving the research and development of blood sugar monitoring technology and new products, but also actively devotes itself to China's diabetes education industry. Wenjie OneTouch has established cooperative relationships with hospitals across the country to promote diabetes education; cooperates with medical associations in various provinces and cities to establish diabetes education centers; carry out self-monitoring education for diabetic patients, free diabetes diagnosis and other activities; and cooperate with the Diabetes Branch of the Chinese Medical Association , sponsors the National Diabetes Census and Diabetes Academic Conference to further popularize self-monitoring and management knowledge of diabetes. Wenjie OneTouch's contribution to China's diabetes industry has been unanimously recognized by professional medical staff and patients, and has now become a leader and innovator in the field of blood sugar monitoring. For more than 30 years, LifeScan, the manufacturer of Wenjie OneTouch products, has been unswervingly committed to improving the quality of life of patients with diabetes. In 2019, Lefscon Group, the manufacturer of Wenjie OneTouch products, set up its Asian headquarters in Shanghai, relying on Lefscon (Shanghai) Medical Equipment Co., Ltd. to provide services to patients with diabetes in the Asia-Pacific region. Currently, there are more than 122 million diabetes patients in China, accounting for nearly one-tenth of the population. The number of diabetes patients in China ranks first in the world. Faced with such a huge market and the urgent need for blood sugar monitoring products from patients, the various blood sugar monitoring products and management solutions provided by Lefscon can just meet the performance needs of patients. At the same time, the investment in the new headquarters demonstrates the strategic significance of the Chinese market to Lefscon, and the company's determination to continue to develop and enhance its leadership in this key region. For more than 40 years, Lefscon has been unswervingly paying attention to patients' blood sugar monitoring and management, and has made unremitting efforts in diabetes health knowledge, committed to improving the quality of life of diabetic patients. Today, Wenjie OneTouch continues to be at the forefront of R&D, promoting professional monitoring and management for diabetes, and continuously improving the research and development and creation of blood sugar monitoring technology and new products, with more than 20 million loyal users around the world. Wenjie OneTouch's contribution to the diabetes industry has been unanimously recognized by professional medical staff and patients at home and abroad.
Johnson & Johnson (China) Investment Co., Ltd.
Wenjie OneTouch was originally affiliated to Johnson & Johnson Group, a century-old international brand. It is a sub-brand of Johnson & Johnson, a subsidiary of the United States that specializes in the production of blood sugar monitoring products (JPY is referred to as Johnson & Johnson's blood sugar meter for short). Now Johnson & Johnson's blood sugar meter has been renamed Wenjie blood sugar meter. In 1987, the Wenjie OneTouch brand was born, becoming a milestone in the development history of pocket blood glucose meters. In 1994, Johnson & Johnson introduced Steady OneTouch to the Chinese market to help Chinese diabetic patients monitor and control blood sugar. Since entering the Chinese market, Wenjie OneTouch has not only been committed to continuously improving the research and development of blood sugar monitoring technology and new products, but also actively devotes itself to China's diabetes education industry. Wenjie OneTouch has established cooperative relationships with hospitals across the country to promote diabetes education; cooperates with medical associations in various provinces and cities to establish diabetes education centers; carry out self-monitoring education for diabetic patients, free diabetes diagnosis and other activities; and cooperate with the Diabetes Branch of the Chinese Medical Association , sponsors the National Diabetes Census and Diabetes Academic Conference to further popularize self-monitoring and management knowledge of diabetes. Wenjie OneTouch's contribution to China's diabetes industry has been unanimously recognized by professional medical staff and patients, and has now become a leader and innovator in the field of blood sugar monitoring. For more than 30 years, LifeScan, the manufacturer of Wenjie OneTouch products, has been unswervingly committed to improving the quality of life of patients with diabetes. In 2019, Lefscon Group, the manufacturer of Wenjie OneTouch products, set up its Asian headquarters in Shanghai, relying on Lefscon (Shanghai) Medical Equipment Co., Ltd. to provide services to patients with diabetes in the Asia-Pacific region. Currently, there are more than 122 million diabetes patients in China, accounting for nearly one-tenth of the population. The number of diabetes patients in China ranks first in the world. Faced with such a huge market and the urgent need for blood sugar monitoring products from patients, the various blood sugar monitoring products and management solutions provided by Lefscon can just meet the performance needs of patients. At the same time, the investment in the new headquarters demonstrates the strategic significance of the Chinese market to Lefscon, and the company's determination to continue to develop and enhance its leadership in this key region. For more than 40 years, Lefscon has been unswervingly paying attention to patients' blood sugar monitoring and management, and has made unremitting efforts in diabetes health knowledge, committed to improving the quality of life of diabetic patients. Today, Wenjie OneTouch continues to be at the forefront of R&D, promoting professional monitoring and management for diabetes, and continuously improving the research and development and creation of blood sugar monitoring technology and new products, with more than 20 million loyal users around the world. Wenjie OneTouch's contribution to the diabetes industry has been unanimously recognized by professional medical staff and patients at home and abroad.
Tianjin iHealth Medical Instruments Co., Ltd.
iHealth, founded in Silicon Valley, USA in 2011, is an independent innovative mobile Internet brand under Jiuan Medical. The company launched a mobile Internet blood pressure monitor connected to Apple mobile phones, which received strong support from Apple in the United States and entered Apple's online official website and offline store channels. The company launches new products at the rate of 2-3 mobile Internet products every year, covering the fields of body temperature, blood pressure, blood sugar, blood oxygen, electrocardiogram, heart rate, weight, body fat, sleep, exercise, etc. The company integrates smart hardware, mobile applications and cloud services to form an ecosystem of personal health management.
Tianjin iHealth Medical Instruments Co., Ltd.
iHealth, founded in Silicon Valley, USA in 2011, is an independent innovative mobile Internet brand under Jiuan Medical. The company launched a mobile Internet blood pressure monitor connected to Apple mobile phones, which received strong support from Apple in the United States and entered Apple's online official website and offline store channels. The company launches new products at the rate of 2-3 mobile Internet products every year, covering the fields of body temperature, blood pressure, blood sugar, blood oxygen, electrocardiogram, heart rate, weight, body fat, sleep, exercise, etc. The company integrates smart hardware, mobile applications and cloud services to form an ecosystem of personal health management.
